25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel

被引：16

作者：

Grieve, Andrew P. ^{[1
]}

机构：

[1] Kings Coll London, Dept Publ Hlth Sci, London 3C1 3QD, England

来源：

PHARMACEUTICAL STATISTICS | 2007年 / 6卷 / 04期

关键词：

bayesian methods; pharmaceutical R & D bioequivalence; LD50; crossover; pharmacoeconomics;

D O I：

10.1002/pst.315

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Twenty-five years ago the use of Bayesian methods in Pharmaceutical R&D was non-existent. Today that is no longer true. In this paper I describe my own personal journey along the road of discovery of Bayesian methods to routine use in the pharmaceutical industry. Copyright (c) 2007 John Wiley & Sons, Ltd.

引用

页码：261 / 281

页数：21

共 101 条

[1]

AITCHISON J, 1964, J ROY STAT SOC B, V26, P161

[2] Statistical issues: a roundtable discussion [J].

Alderson, NE ;

Campbell, G ;

D'Agostino, R ;

Ellenberg, S ;

Lindborg, S ;

O'Neill, R ;

Rubin, D ;

Siegel, J .

CLINICAL TRIALS, 2005, 2 (04) :364-372

[3]

[Anonymous], APPL STAT, DOI DOI 10.2307/2347565

[4]

[Anonymous], 2000, WINBUGS VERSION 1 4

[5] Bayesian statistics in medicine: A 25 year review [J].

Ashby, Deborah .

STATISTICS IN MEDICINE, 2006, 25 (21) :3589-3631

[6]

Babb J, 1998, STAT MED, V17, P1103, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO

[7]

2-9

[8] TESTING EQUIVALENCE SIMULTANEOUSLY FOR LOCATION AND DISPERSION OF 2 NORMALLY DISTRIBUTED POPULATIONS [J].

BAUER, P ;

BAUER, MM .

BIOMETRICAL JOURNAL, 1994, 36 (06) :643-660

[9]

Bernardo J., 2009, Bayesian theory

[10]

BERRES M, 1991, J EXP ANIM SCI, V34, P21

← 1 2 3 4 5 6 7 8 9 10 →